Iradimed Corp Company Profile (NASDAQ:IRMD)

About Iradimed Corp (NASDAQ:IRMD)

Iradimed Corp logoIRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:IRMD
  • CUSIP: N/A
  • Web: www.iradimed.com
Capitalization:
  • Market Cap: $89.22 million
  • Outstanding Shares: 10,749,000
Average Prices:
  • 50 Day Moving Avg: $8.46
  • 200 Day Moving Avg: $9.59
  • 52 Week Range: $7.85 - $22.53
P/E:
  • Trailing P/E Ratio: 20.75
  • Foreward P/E Ratio: 33.20
  • P/E Growth: 4.36
Sales & Book Value:
  • Annual Revenue: $28.69 million
  • Price / Sales: 3.11
  • Book Value: $2.98 per share
  • Price / Book: 2.79
Profitability:
  • EBIDTA: $7.47 million
  • Net Margins: 22.20%
  • Return on Equity: 24.50%
  • Return on Assets: 21.37%
Debt:
  • Current Ratio: 9.69%
  • Quick Ratio: 8.67%
Misc:
  • Average Volume: 42,374 shs.
  • Beta: 1.66
  • Short Ratio: 19.55
 

Frequently Asked Questions for Iradimed Corp (NASDAQ:IRMD)

What is Iradimed Corp's stock symbol?

Iradimed Corp trades on the NASDAQ under the ticker symbol "IRMD."

How were Iradimed Corp's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) issued its quarterly earnings data on Friday, April, 28th. The company reported ($0.02) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.02). The company had revenue of $5.16 million for the quarter, compared to the consensus estimate of $5.26 million. Iradimed Corp had a return on equity of 24.50% and a net margin of 22.20%. The firm's revenue for the quarter was down 42.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.21 earnings per share. View Iradimed Corp's Earnings History.

What guidance has Iradimed Corp issued on next quarter's earnings?

Iradimed Corp issued an update on its FY17 earnings guidance on Friday, April, 28th. The company provided earnings per share guidance of $0.03-$0.04 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.16. The company issued revenue guidance of $22.7-$23.1 million, compared to the consensus revenue estimate of $23.90 million.Iradimed Corp also updated its Q2 guidance to ($0.01)-$0.00 EPS.

Where is Iradimed Corp's stock going? Where will Iradimed Corp's stock price be in 2017?

1 brokers have issued 12-month price objectives for Iradimed Corp's stock. Their forecasts range from $11.50 to $11.50. On average, they expect Iradimed Corp's share price to reach $11.50 in the next year. View Analyst Ratings for Iradimed Corp.

Who are some of Iradimed Corp's key competitors?

Who owns Iradimed Corp stock?

Iradimed Corp's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.18%), Mondrian Investment Partners LTD (1.92%), AQR Capital Management LLC (1.28%), Granite Investment Partners LLC (1.10%), Municipal Employees Retirement System of Michigan (1.08%) and Globeflex Capital L P (0.79%). Company insiders that own Iradimed Corp stock include Brent Johnson, James B Hawkins, Monty K Allen, Roger E Susi, Serge Novovich and Steven M Nardi. View Institutional Ownership Trends for Iradimed Corp.

Who sold Iradimed Corp stock? Who is selling Iradimed Corp stock?

Iradimed Corp's stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Renaissance Technologies LLC, Granite Investment Partners LLC, TIAA CREF Investment Management LLC and Spark Investment Management LLC. Company insiders that have sold Iradimed Corp stock in the last year include Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed Corp.

Who bought Iradimed Corp stock? Who is buying Iradimed Corp stock?

Iradimed Corp's stock was purchased by a variety of institutional investors in the last quarter, including Mondrian Investment Partners LTD, Globeflex Capital L P, Goldman Sachs Group Inc., Oxford Asset Management, AQR Capital Management LLC, Vanguard Group Inc., Morgan Stanley and Neuberger Berman Group LLC. View Insider Buying and Selling for Iradimed Corp.

How do I buy Iradimed Corp stock?

Shares of Iradimed Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Iradimed Corp stock cost?

One share of Iradimed Corp stock can currently be purchased for approximately $8.30.

Analyst Ratings

Consensus Ratings for Iradimed Corp (NASDAQ:IRMD) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $11.50 (38.55% upside)

Analysts' Ratings History for Iradimed Corp (NASDAQ:IRMD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/5/2016Roth CapitalDowngradeBuy -> Neutral$28.00 -> $11.50N/AView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Iradimed Corp (NASDAQ:IRMD)
Earnings by Quarter for Iradimed Corp (NASDAQ:IRMD)
Earnings History by Quarter for Iradimed Corp (NASDAQ:IRMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/28/2017Q1 2017($0.02)($0.02)$5.26 million$5.16 millionViewN/AView Earnings Details
2/6/2017Q416$0.04$0.11$6.09 million$6.00 millionViewListenView Earnings Details
10/28/2016Q316$0.09$0.14$7.50 million$7.70 millionViewListenView Earnings Details
7/29/2016Q216$0.21$0.24$9.60 million$9.90 millionViewListenView Earnings Details
4/29/2016Q1$0.18$0.21$9.05 million$8.96 millionViewListenView Earnings Details
2/5/2016Q415$0.19$0.22$8.80 million$8.80 millionViewN/AView Earnings Details
10/30/2015Q315$0.16$0.19$7.70 million$8.20 millionViewListenView Earnings Details
7/30/2015Q215$0.12$0.15$7.10 million$7.60 millionViewListenView Earnings Details
4/30/2015Q115$0.10$0.12$6.90 million$7.00 millionViewN/AView Earnings Details
2/5/2015Q4($0.01)$0.02$3.50 million$3.58 millionViewN/AView Earnings Details
10/30/2014Q3$0.01$0.02$3.80 million$3.80 millionViewN/AView Earnings Details
8/12/2014Q214$0.11$2.80 million$4.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Iradimed Corp (NASDAQ:IRMD)
2017 EPS Consensus Estimate: $0.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.02)($0.02)($0.02)
Q2 20171$0.00$0.00$0.00
Q3 20171$0.03$0.03$0.03
Q4 20171$0.07$0.07$0.07
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Iradimed Corp (NASDAQ:IRMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Iradimed Corp (NASDAQ:IRMD)
Insider Ownership Percentage: 69.00%
Institutional Ownership Percentage: 22.86%
Insider Trades by Quarter for Iradimed Corp (NASDAQ:IRMD)
Institutional Ownership by Quarter for Iradimed Corp (NASDAQ:IRMD)
Insider Trades by Quarter for Iradimed Corp (NASDAQ:IRMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2017Roger E SusiCEOBuy10,000$8.60$86,000.00View SEC Filing  
11/29/2016Roger E SusiCEOBuy5,000$11.24$56,200.00View SEC Filing  
11/15/2016Roger E SusiCEOBuy5,000$10.46$52,300.00View SEC Filing  
8/16/2016Steven M NardiVPSell2,096$17.11$35,862.56View SEC Filing  
6/14/2016Monty K. AllenDirectorSell2,275$20.00$45,500.00View SEC Filing  
6/13/2016Monty K AllenDirectorSell2,100$20.44$42,924.00View SEC Filing  
2/19/2016Serge NovovichDirectorSell2,910$17.23$50,139.30View SEC Filing  
2/18/2016Steven M NardiVPSell192$17.00$3,264.00View SEC Filing  
12/23/2015Roger E SusiCEOSell156,521$23.28$3,643,808.88View SEC Filing  
12/18/2015Roger E SusiCEOSell1,043,479$23.28$24,292,191.12View SEC Filing  
12/16/2015Steven M. NardiVPSell4,438$26.80$118,938.40View SEC Filing  
12/8/2015Brent JohnsonVPSell22,659$30.92$700,616.28View SEC Filing  
12/7/2015Steven M. NardiVPSell624$31.02$19,356.48View SEC Filing  
12/4/2015Brent JohnsonVPSell400$31.51$12,604.00View SEC Filing  
12/3/2015Brent JohnsonVPSell26,880$31.52$847,257.60View SEC Filing  
12/1/2015Serge NovovichDirectorSell1,000$31.12$31,120.00View SEC Filing  
11/25/2015James B. HawkinsDirectorSell5,290$30.98$163,884.20View SEC Filing  
8/25/2015Monty K. AllenDirectorSell6,250$24.85$155,312.50View SEC Filing  
12/29/2014Steven M NardiVPBuy2,100$12.58$26,418.00View SEC Filing  
7/21/2014James B HawkinsDirectorBuy80,000$6.25$500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Iradimed Corp (NASDAQ:IRMD)
Latest Headlines for Iradimed Corp (NASDAQ:IRMD)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : May 22, 2017
finance.yahoo.com - May 22 at 5:27 PM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : May 9, 2017
finance.yahoo.com - May 9 at 5:45 PM
finance.yahoo.com logoIRadimed Corp. :IRMD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 8 at 5:37 PM
americanbankingnews.com logoSomewhat Negative Media Coverage Likely to Impact Iradimed Corp (IRMD) Share Price
www.americanbankingnews.com - May 2 at 9:38 PM
americanbankingnews.com logoIradimed Corp (IRMD) Earns Daily News Impact Score of 0.04
www.americanbankingnews.com - April 29 at 11:59 PM
finance.yahoo.com logoEdited Transcript of IRMD earnings conference call or presentation 28-Apr-17 3:00pm GMT
finance.yahoo.com - April 29 at 9:08 AM
americanbankingnews.com logoIradimed Corp (IRMD) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - April 29 at 1:27 AM
americanbankingnews.com logoIradimed Corp (IRMD) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - April 29 at 1:22 AM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : April 28, 2017
finance.yahoo.com - April 28 at 6:57 PM
americanbankingnews.com logoIradimed Corp (IRMD) Issues FY17 Earnings Guidance
www.americanbankingnews.com - April 28 at 10:21 AM
americanbankingnews.com logoIradimed Corp (IRMD) Updates Q2 Earnings Guidance
www.americanbankingnews.com - April 28 at 10:20 AM
finance.yahoo.com logoIRADIMED CORPORATION Announces First Quarter 2017 Financial Result
finance.yahoo.com - April 28 at 9:55 AM
finance.yahoo.com logoIRadimed reports 1Q loss
finance.yahoo.com - April 28 at 9:55 AM
finance.yahoo.com logoInvestor Network: iRadimed Corp to Host Earnings Call
finance.yahoo.com - April 28 at 9:55 AM
americanbankingnews.com logoIradimed Corp (IRMD) Earning Favorable News Coverage, Analysis Shows
www.americanbankingnews.com - April 21 at 10:13 PM
finance.yahoo.com logoIRADIMED CORPORATION to Hold 2017 First Quarter Financial Results Conference Call on April 28th
finance.yahoo.com - April 20 at 11:23 AM
americanbankingnews.com logoIradimed Corp (IRMD) Given Coverage Optimism Rating of -0.12
www.americanbankingnews.com - April 18 at 6:51 PM
americanbankingnews.com logoIradimed Corp (IRMD) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:51 AM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : April 7, 2017
finance.yahoo.com - April 7 at 5:50 PM
americanbankingnews.com logo Iradimed Corp (IRMD) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 3 at 11:37 PM
streetinsider.com logoIradimed Corp. (IRMD) Names John McCreery as COO
www.streetinsider.com - March 30 at 11:20 PM
finance.yahoo.com logoIRADIMED Names John McCreery Chief Operating Officer
finance.yahoo.com - March 30 at 6:20 PM
biz.yahoo.com logoIRADIMED CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - March 30 at 6:20 PM
americanbankingnews.com logoIradimed Corp (IRMD) Lifted to “Hold” at Zacks Investment Research
www.americanbankingnews.com - March 19 at 7:01 PM
biz.yahoo.com logoIRADIMED CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 10 at 7:11 PM
finance.yahoo.com logoIRADIMED CORPORATION to Present at 29th Annual Roth Conference
finance.yahoo.com - March 9 at 7:19 AM
finance.yahoo.com logoEdited Transcript of IRMD earnings conference call or presentation 6-Feb-17 4:00pm GMT
finance.yahoo.com - February 16 at 9:51 PM
finance.yahoo.com logoEdited Transcript of IRMD earnings conference call or presentation 6-Feb-17 4:00pm GMT
finance.yahoo.com - February 16 at 9:51 PM
seekingalpha.com logoiRadimed Poised For Market Domination
seekingalpha.com - February 15 at 5:25 AM
seekingalpha.com logoIRadimed's (IRMD) CEO Roger Susi on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 8 at 12:16 AM
us.rd.yahoo.com logoIRADIMED CORPORATION Announces Fourth Quarter 2016 Financial Results
us.rd.yahoo.com - February 6 at 10:30 AM
biz.yahoo.com logoQ4 2016 IRadimed Corp Earnings Release - Before Market Open
us.rd.yahoo.com - February 6 at 10:30 AM
finance.yahoo.com logoIRADIMED CORPORATION to Hold 2016 Fourth Quarter Financial Results Conference Call on February 6th
finance.yahoo.com - January 25 at 7:22 PM
globenewswire.com logoIRADIMED CORPORATION Announces 2017 Annual and First Quarter Financial Guidance
globenewswire.com - January 18 at 6:28 PM
seekingalpha.com logoIRADIMED CORPORATION announces FY2017 and Q1 guidance; shares off 19%
seekingalpha.com - January 18 at 6:28 PM
finance.yahoo.com logoIRADIMED CORPORATION Announces First Shipments of Its MRI Compatible Patient Vital Signs Monitor
finance.yahoo.com - January 3 at 11:30 AM
us.rd.yahoo.com logoIRADIMED CORPORATION Receives FDA Clearance for MRI Compatible IV Infusion Pump
us.rd.yahoo.com - December 19 at 11:26 AM
us.rd.yahoo.com logo7:05 am iRadimed receives 510(k) clearance for its MRidium 3860+ magnetic resonance imaging compatible IV infusion pump system, including its Dose Error Reduction System software feature
us.rd.yahoo.com - December 19 at 11:26 AM
finance.yahoo.com logoIRADIMED CORP Financials
finance.yahoo.com - November 11 at 5:17 PM
finance.yahoo.com logoEdited Transcript of IRMD earnings conference call or presentation 28-Oct-16 3:00pm GMT
finance.yahoo.com - November 8 at 5:07 PM
finance.yahoo.com logo7:14 am iRadimed beats by $0.03, beats on revs; guides Q4 EPS in-line, revs in-line
finance.yahoo.com - October 29 at 5:28 PM
nasdaq.com logoIRADIMED CORPORATION Announces Third Quarter 2016 Financial Results
www.nasdaq.com - October 28 at 9:07 AM
finance.yahoo.com logoIRADIMED CORPORATION to Hold 2016 Third Quarter Financial Results Conference Call on October 28th
finance.yahoo.com - October 18 at 10:49 AM
finance.yahoo.com logoiRadimed downgraded by ROTH Capital
finance.yahoo.com - October 5 at 5:35 PM
streetinsider.com logoPre-Open Stock Movers 10/04: (SMMT) (SDRL) (ARLZ) Higher; (TRIB) (IRMD) (TWTR) Lower (more...)
www.streetinsider.com - October 5 at 10:55 AM
benzinga.com logoIradimed Sinks 30% On Sharply Cut Guidance
www.benzinga.com - October 5 at 10:55 AM
globenewswire.com logoIRADIMED CORPORATION Revises Financial Guidance for the Third Quarter and Full Year 2016
globenewswire.com - October 5 at 10:55 AM
rttnews.com logoIradimed Corp. (IRMD) Plunged To A New Low After Outlook Slashed
www.rttnews.com - October 5 at 10:55 AM
biz.yahoo.com logoIRADIMED CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - October 4 at 10:26 AM
seekingalpha.com logoIRadimed Corp. (IRMD) CEO Roger Susi on Q2 2016 Results - Earnings Call Transcript
seekingalpha.com - July 31 at 5:22 PM

Social

Chart

Iradimed Corp (IRMD) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff